Quality on Both Sides of the Atlantic
Schreiner MediPharm L.P. Passes Certification Audits
Oberschleissheim, May 20, 2010 – Schreiner MediPharm is pleased to announce that its U.S. operation Schreiner MediPharm L.P. in Blauvelt, New York, has achieved another milestone. The facility has successfully completed audits confirming its compliance with international standards and processes. The certifications demonstrate that the U.S. site now officially operates according to the same quality and environmental management as well as occupational health and safety standards as all other Schreiner Group locations.
Innovation, Quality, Performance and Enthusiasm – Schreiner Group’s new production plant in the United States lives the same corporate values as the German parent group. The certification of the facility according to the international ISO 9001 (Quality Management System), ISO 14001 (Environmental Management System) and OHSAS 18001 (Occupational Health and Safety System) standards has provided important proof of this commitment.
The certifications which have now also been awarded to the U.S. facility give customers assurance that they can count on a reliable quality supplier who uses the same processes and standards worldwide. The facilities thus provide customers with tested reliability as respective back-up production sites within the scope of global risk management.
For further information, contact:
Schreiner MediPharm, a business unit of
Schreiner Group GmbH & Co. KG
Bruckmannring 22
85764 Oberschleissheim
Germany
Phone +49 89 31584-5400
Fax +49 89 31584-5422
info@schreiner-medipharm.com







